Studies in mice showed that CCR2 deficiency or antagonism of this receptor resulted in attenuation of systemic insulin resistance and development of obesity, hence suggesting a modulating role of CCR2 in this[39,40]. The gene discussed is CCR2; the disease is Insulin resistance.